Clinical Trial Update: Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating interleukin-2 in patients with Mycosis fungoides or Sézary syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Northwestern University | Conditions: Lymphoma | Phase 2 | Status: TERMINATED